AntagomiR-based therapy for M.Tuberculosis: Yes-associated protein-1 suppresses IFN-γ via up regulation of its target gene, 9/July/2014, 04.14 am
Idea Proposed/Formulated by: Dr L Boominathan PhD Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, L., AntagomiR-based therapy for M.Tuberculosis: Yes-associated protein-1 suppresses IFN-γ via up regulation of its target gene, 9/July/2014, 04.14 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org
Anti-miRNA based therapy for Human cancer: MiRNA-216a/217 increases the expression of immortality gene telomerase via down regulation of its target gene, 9/July/2014, 04.11 am
Idea Proposed/Formulated by: Dr L Boominathan PhD Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, L., Anti-miRNA based therapy for Human cancer: MiRNA-216a/217 increases the expression of immortality gene telomerase via down regulation of its target gene, 9/July/2014, 04.11 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org
Treating Tuberculosis with Green tea: High dose of Epigallocatechin 3-Gallate inhibits the pathogenesis and progression of Tuberculosis (Mtb) via up regulation of its target gene, 8/July/2014, 9.18 am
A study from the Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA has reported that “Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk.” This study was published in the June 25, 2014 Nature by Prof. Sher, Mayer-Barber Katrin D and others from the Immunobiology Section, Laboratory of Parasitic Diseases, National Institute […]
MiRNAs-based treatment for inflammation-mediated insulin resistance and steatosis: MiRNA-378 decreases metabolic inflammation and insulin resistance via down regulation of its target gene, 8/July/2014, 8.46 am
Prof. Harald Esterbauer, Alexander Jais and others, from Vienna, Austria, has reported recently in the July 3, 2014 Cell (I.F: 31.957) that “Heme Oxygenase-1 Drives Metaflammation and Insulin Resistance in Mouse and Man.” On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: MiRNAs-based treatment for inflammation-mediated insulin resistance and steatosis: MiRNA-378 decreases metabolic inflammation and insulin […]
Natural product-based therapeutics for Inflammatory cardiac disease: Resveratrol, a longevity promoting drug, inhibits Inflammatory dilated cardiomyopathy (DCMi) via down regulation of its target gene, 6/July/2014, 8.00 am
A study from W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Department of Pathology, and Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA has reported that IL-17 mediates Inflammatory cardiac diseases. This study was published in the June 16, 2014 JEM [I.F >15] by Prof. Daniela Čiháková, Lei Wu and others from […]
MiRNAs-based therapy for Cardiovascular and metabolic disorders: MiRNA-138 improves cardiovascular and metabolic abnormalities via down regulation of its target gene, 8/July/2014, 7.30 am
A study from the Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; and PRESTO, Japan Science and Technology Agency, Saitama, Japan has reported that “Inhibition of Endothelial p53 Improves Metabolic Abnormalities..” This study was published in the June 12, 2014 Cell Reports by Prof. Minamino T, Yokoyama and others from the Department of Cardiovascular Medicine, Niigata University Graduate School of Medical […]